CORRECTING and REPLACING Clovis Oncology Announces Second Quarter 2022 Financial Results and Hosts Webcast Conference Call on August 8th

BOULDER, CO–(BUSINESS WIRE)–First paragraph, second sentence of press release to read: Clovis management will host a conference call and live audio webcast at 8:30 am ET to discuss Clovis’ results and business prospects in more detail. (A conference call and live audio webcast will be held in lieu of Clovis management at 6:30 am ET to further discuss Clovis’ results and business prospects.)

The updated version is:

CLOVIS ONCOLOGY ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS AND WILL HOST WEBCAST CONFERENCE CALL ON AUGUST 8TH

Clovis Oncology, Inc. (NASDAQ: CLVS) will report its second quarter 2022 financial results and an update on its clinical development programs, regulatory and business outlook on Monday, August 8, 2022, ahead of the opening up of U.S. financial markets give. Clovis management will host a conference call and live audio webcast at 8:30 am ET to discuss Clovis’ results and business prospects in more detail.

The conference call will be simultaneously webcast on Clovis Oncology’s website at www.clovisoncology.com and a replay of the webcast will be available for 30 days.

The dial-in numbers for the conference call are as follows: US participants 888.440.4615 International participants 646.960.0682, Conference ID: 2259685.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative cancer medicines in the US, Europe and additional international markets. Clovis Oncology targets development programs to specific subsets of cancer populations while also developing diagnostic tools with partners that aim to target a drug under development to the population most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado; Please visit www.clovisoncology.com for more information, including additional office locations in the US and Europe.